Gil Bar-Nahum

Managing Director at Jefferies International

Speaker

Dr. Gil Bar-Nahum is a Managing Director and EMEA Head of Biotechnology in the Global Healthcare Investment Banking Group at Jefferies, based in London. He leads the team with a primary focus on innovative companies in Europe and Israel. Dr. Bar-Nahum has over 20 years of investment banking experience and has executed transactions for biotechnology, pharmaceutical, medical technology, and life science tools companies. In the last several years, Dr. Bar-Nahum has led the execution of more than 60 financings, including 30+ IPOs for foreign private issuers (on NASDAQ), raising more than US$5.0Bn. Since joining Jefferies in 2009, Dr Bar-Nahum has also advised on more than a dozen cross-border M&A transactions and strategic partnerships. From 2002-2009 Dr. Bar-Nahum was part of UBS Investment Bank's Global Healthcare Group, based primarily in the US. Prior to that, Dr. Bar-Nahum worked as an Equity Research Analyst for UBS where he served as an Associate Director covering companies in the Life Science Tools and Biotechnology space. Dr. Bar-Nahum received his PhD in Basic Medical Sciences from the Department of Biochemistry at the Sackler Institute of New York University School of Medicine. The subject of Dr. Bar-Nahum's doctorate work was published twice in the journal Cell. Dr. Bar-Nahum also received an MS from New York University’s School of Medicine in Cell and Molecular Biology and a BS from the University of Illinois in Microbiology.